Related Experiment Video
Updated: Apr 8, 2026

Testing Sensory and Multisensory Function in Children with Autism Spectrum Disorder
Published on: April 22, 2015
Melatonin in Children with Autism Spectrum Disorders: How Does the Evidence Fit Together?
Olivia J Veatch1, Suzanne E Goldman2, Karen W Adkins1
1Sleep Disorders Division, Department of Neurology, Vanderbilt University Medical Center, Nashville, TN, USA.
Insights
Children with autism spectrum disorder (ASD) often experience insomnia due to issues with the melatonin pathway. Genetic variations in melatonin regulation may increase the risk of sleep disorders in ASD.
Area of Science:
- Neurodevelopmental disorders
- Sleep medicine
- Genetics
Background:
- Autism spectrum disorder (ASD) affects 1 in 68 children in the US.
- Sleep disturbances, especially insomnia, are common in children with ASD.
- Overlapping neurobiological and genetic factors link ASD and insomnia.
Purpose of the Study:
- To review genetic variations in the melatonergic pathway and their effect on sleep disorders in children with ASD.
- To evaluate functional findings of endogenous melatonin levels and pharmacokinetics in ASD.
Main Methods:
- Literature review of studies on ASD, insomnia, and the melatonin pathway.
- Analysis of genetic variation in melatonin-regulating genes.
- Evaluation of endogenous melatonin levels and pharmacokinetic data in ASD.
Main Results:
- Dysregulation of the melatonin pathway is frequently observed in individuals with ASD.
- Genetic variations in melatonin-related genes are implicated in ASD and sleep pattern modification.
- The interplay between ASD, insomnia, and melatonin regulation is complex.
Conclusions:
- Genetic variations in the melatonergic pathway may influence the risk of sleep disorders in children with ASD.
- Further research is needed to fully understand the relationship between melatonin, genetics, and sleep in ASD.
- Melatonin pathway dysregulation is a significant factor in ASD-related sleep issues.
Abstract:
Autism spectrum disorders (ASD) are prevalent neurodevelopmental conditions, affecting 1 in 68 children in the United States alone. Sleep disturbance, particularly insomnia, is very common in children diagnosed with ASD, with evidence supporting overlapping neurobiological and genetic underpinnings. One of the most well studied mechanisms related to ASD and insomnia is dysregulation of the melatonin pathway, which has been observed in many individuals with ASD compared to typically developing controls. Furthermore, variation in genes whose products regulate endogenous melatonin modify sleep patterns in humans and have also been implicated in some cases of ASD. However, the relationship between comorbid insomnia, melatonin processing, and genes that regulate endogenous melatonin levels in ASD is complex and requires further study to fully elucidate. The aim of this review is to provide an overview of the current findings related to the effects of genetic variation in the melatonergic pathway on risk for expression of sleep disorders in children with ASD. In addition, functional findings related to endogenous levels of melatonin and pharmacokinetic profiles in this patient population are evaluated.
Related Concept Videos
Autism Spectrum Disorder
These core symptoms manifest differently among individuals, ranging from mild to severe. The disorder's complexity extends beyond its clinical presentation, encompassing a diverse range of biological, cognitive, and sociocultural influences.
Management of Insomnia
Nightmares and Night Terrors
Nightmares...
Modeling in Therapy
Participant Modeling
Participant modeling involves therapists demonstrating calm and effective behaviors in...
REM Sleep Behavior Disorder
RBD is significantly associated with...
Narcolepsy

